Immunoblot detection of soluble protein antigens from sodium dodecyl sulfate- and sodium deoxycholate-treated candidate bioscaffold tissues

Journal of Heart Valve Disease

Volumn 18, Issue 4, 2009, Pages 439-443

  Arai, Shiori ^a   Orton, E Christopher ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DEOXYCHOLIC ACID; DETERGENT; DODECYL SULFATE SODIUM; TISSUE SCAFFOLD;

ANIMAL; AORTA VALVE; ARTICLE; BIOPROSTHESIS; CATTLE; CYTOLOGY; HEART VALVE PROSTHESIS; IMMUNOBLOTTING; IMMUNOLOGY; METHODOLOGY; PERICARDIUM; RABBIT; SWINE;

ANIMALS; ANTIGENS; AORTIC VALVE; BIOPROSTHESIS; CATTLE; CYTOLOGICAL TECHNIQUES; DEOXYCHOLIC ACID; DETERGENTS; HEART VALVE PROSTHESIS; IMMUNOBLOTTING; PERICARDIUM; RABBITS; SODIUM DODECYL SULFATE; SWINE; TISSUE SCAFFOLDS;

EID: 79551497295     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003; 23:1002-1006
2. Schreiber C, Eicken A, Seidl S, Lange R. Unexpected early failure of a decellularized right ventricle to pulmonary artery graft. Ann Thorac Surg 2008; 86:2026-2027
3. Kasimir MT, Rieder E, Seebacher G, et al. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis 2006; 15:278-286
4. Bastian F, Stelzmüller ME, Kratochwill K, Kasimir MT, Simon P, Weigel G. IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue. Biomaterials 2008; 29:1824-1832
5. Rieder E, Nigisch A, Dekan B, et al. Granulocyte-based immune response against decellularized or glutaraldehyde cross-linked vascular tissue. Biomaterials 2006; 27:5634-5642
6. Rieder E, Seebacher G, Kasimir MT, et al. Tissue engineering of heart valves: Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005; 111:2792-2797
7. Tudorache I, Cebotari S, Sturz G, et al. Tissue engineering of heart valves: Biomechanical and morphological properties of decellularized heart valves. J Heart Valve Dis 2007; 16:567-573
8. Booth C, Korossis SA, Wilcox HE, et al. Tissue engineering of cardiac valve prostheses. I: Development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 2002; 11:457-462
9. Wilcox HE, Korossis SA, Booth C, et al. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix. J Heart Valve Dis 2005; 14:228-236
10. Kim WG, Park JK, Lee WY. Tissue-engineered heart valve leaflets: An effective method of obtaining acellularized valve xenografts. Int J Artif Organs 2002; 25:791-797
11. Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 2008; 14: 213-221
12. Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 2002; 74: 1438-1442
13. Lichtenberg A, Tudorache I, Cebotari S, et al. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions. Biomaterials 2006; 27: 4221-4229
14. Grauss RW, Hazekamp MG, van Vliet S, Gittenberger-de Groot AC, DeRuiter MC. Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling. J Thorac Cardiovasc Surg 2003; 126:2003-2010
15. Schenke-Layland K, Vasilevski O, Opitz F, et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 2003; 143:201-208
16. Goldstein S, Clarke DR, Walsh SP, Black KS, O'Brien MF. Transpecies heart valve transplant: Advanced studies of a bioengineered xeno-auto-graft. Ann Thorac Surg 2000; 70:1962-1969
17. Gonçalves AC, Griffiths LG, Anthony RV, Orton EC. Decellularization of bovine pericardium for tissue engineering by targeted removal of xenoantigens. J Heart Valve Dis 2005; 14:212-217
18. Woods T, Gratzer PR Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft. Biomaterials 2005; 26:7339-7349
19. Kasimir MT, Rieder E, Seebacher G, Wolner E, Weigel G, Simon P. Presence and elimination of the xenoantigen gal (alphal, 3) gal in tissue-engineered heart valves. Tissue Eng 2005; 11:1274-1280
20. Lü WD, Zhang M, Wu ZS, Hu TH. Decellularized and photooxidatively crosslinked bovine jugular veins as potential tissue engineering scaffolds. Interact Cardiovasc Thorac Surg 2009; 8:301-305
21. Griffiths LG, Chloe L, Reardon KF, Dow SW, Orton EC. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials 2008; 29:3514-3520
22. Iwai S, Torikai K, Coppin CM, Sawa Y. Minimally immunogenic decellularized porcine valve provides in situ recellularization as a stentless bioprosthetic valve. J Artif Organs 2007; 10:29-35
23. Ueda Y, Torrianni MW, Coppin CM, Iwai S, Sawa Y, Matsuda H. Antigen clearing from porcine heart valves with preservation of structural integrity. Int J Artif Organs 2006; 29:781-789